Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide schedule comparison in children with recurrent or refractory CNS tumors
NL-OMON28755Recruiting
- Sponsor
- SKion
- Start
- Jan 2004
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of temozolomide in primitive neuroectodermal tumor (PNET), glioma and central nervous system tumor (2 arms), sponsored by SKion. Started Jan 2004; status: recruiting.
02
Drugs
temozolomide
03
Conditions
primitive neuroectodermal tumor (PNET)gliomacentral nervous system tumor
Beyond the preview
Go deeper on NL-OMON28755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28755.